retatrutide heart palpitations Understanding the Link: Arrhythmias & Rate Changes with High Dose GLP-1s Concerned about HR and heart

For certain serious cases of obesity in the US, medical insurance covers most of the cost

SIRs should be designed around a well-understood risk profile, not introduced as a default response to market pressure

In 2023, medical inflation was 10.7% against an end-of-period CPI of 6%

Research consistently shows that people on GLP-1 medications who don't prioritize protein lose significant amounts of muscle along with fat studies suggest up to 40% of weight lost can be lean muscle mass

This data is valuable because it captures effects in broader populations than clinical trials, including people with comorbidities, those taking multiple medications, and those using doses or schedules that differ from trial protocols

Facial volume loss is a normal, and treatable, part of the process